5/26/2023

Bleomycin Sulfate Injection

Products Affected - Description

- Bleomycin sulfate lyophilized powder for solution for injection, Fresenius Kabi, 30 unit, vial, 1 count, NDC 63323-0137-20
- Bleomycin sulfate, Hikma, 30 unit, vial, 1 count, NDC 00143-9241-01
- Bleomycin sulfate lyophilized powder for solution for injection, Pfizer, 15 unit, vial, 1 count, NDC 61703-0332-18
- Bleomycin sulfate lyophilized powder for solution for injection, Pfizer, 30 unit, vial, 1 count, NDC 61703-0323-22

Reason for the Shortage

- Fresenius Kabi did not provide a reason for the shortage.
- Hikma did not provide a reason for the shortage.
- Pfizer has bleomycin on shortage due to increased demand and manufacturing delays.
- Teva has bleomycin temporarily suspended with no estimated date to resume manufacturing.

Available Products

- Bleomycin sulfate lyophilized powder for solution for injection, Fresenius Kabi, 15 unit, vial, 1 count, NDC 63323-0136-10
- Bleomycin sulfate, Hikma, 15 unit, vial, 1 count, NDC 00143-9240-01
- Bleomycin sulfate, Meitheal Pharmaceuticals, 15 unit, vial, 1 count, NDC 71288-0106-10
- Bleomycin sulfate, Meitheal Pharmaceuticals, 30 unit, vial, 1 count, NDC 71288-0107-20

Estimated Resupply Dates

- Fresenius Kabi has bleomycin 30 unit vials on back order and the company estimates a release date of late-June 2023.
- Hikma has short-dated bleomycin 30 unit vials available with an expiration date of < January 2024.
- Pfizer has bleomycin 15 unit and 30 unit vials available in limited supply.

Updated

Updated May 26, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 8, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.